Search

Your search keyword '"Biselli M"' showing total 250 results

Search Constraints

Start Over You searched for: Author "Biselli M" Remove constraint Author: "Biselli M"
250 results on '"Biselli M"'

Search Results

201. A new prognostic model to predict dropout from the waiting list in cirrhotic candidates for liver transplantation with MELD score <18.

202. Biomarkers for the early diagnosis of bacterial infection and the surveillance of hepatocellular carcinoma in cirrhosis.

203. Posttranscriptional changes of serum albumin: clinical and prognostic significance in hospitalized patients with cirrhosis.

204. Hepatitis C virus reinfection after liver transplantation: is there a role for direct antiviral agents?

205. A sensitive monitoring system for mammalian cell cultivation processes: a PAT approach.

206. Chip-based amperometric enzyme sensor system for monitoring of bioprocesses by flow-injection analysis.

208. QT interval prolongation by acute gastrointestinal bleeding in patients with cirrhosis.

209. Liver transplantation for patients with alcoholic liver disease: an open question.

210. The MELD score in patients awaiting liver transplant: strengths and weaknesses.

211. Six score systems to evaluate candidates with advanced cirrhosis for orthotopic liver transplant: Which is the winner?

212. Allocation priority in non-urgent liver transplantation: An overview of proposed scoring systems.

213. Anti-HBs re-seroconversion after liver transplantation in a patient with past HBV infection receiving a HBsAg positive graft.

214. Two yr mycophenolate mofetil plus low-dose calcineurin inhibitor for renal dysfunction after liver transplant.

215. Clinical trial: peg-interferon alfa-2b and ribavirin for the treatment of genotype-1 hepatitis C recurrence after liver transplantation.

216. Sustained and focused hepatitis B virus nucleocapsid-specific T-cell immunity in liver transplant recipients compared to individuals with chronic and self-limited hepatitis B virus infection.

217. Hepatocellular carcinoma appearance in patients with hepatitis C virus-related chronic liver disease 90 and 70 months after sustained virological response to interferon and ribavirin.

218. Characterization of photosynthetically active duckweed (Wolffia australiana) in vitro culture by Respiration Activity Monitoring System (RAMOS).

219. A randomized trial of induction doses of interferon alone or in combination with ribavirin or ribavirin plus amantadine for treatment of nonresponder patients with chronic hepatitis C.

220. High incidence of allograft dysfunction in liver transplanted patients treated with pegylated-interferon alpha-2b and ribavirin for hepatitis C recurrence: possible de novo autoimmune hepatitis?

221. Review article: alcoholic liver disease--pathophysiological aspects and risk factors.

222. Pegylated interferon plus ribavirin for recurrent Hepatitis C infection after liver transplantation in naïve and non-responder patients on a stable immunosuppressive regimen.

223. Transcatheter arterial chemoembolization therapy for patients with hepatocellular carcinoma: a case-controlled study.

224. Cytokine profile of peripheral blood mononuclear cells from patients with different outcomes of hepatitis C virus infection.

225. Hepatic artery stenosis in liver transplanted patients treated with pegylated interferon alpha-2b and ribavirin.

226. High risk of hepatocellular carcinoma in anti-HBe positive liver cirrhosis patients developing lamivudine resistance.

227. In vitro effect of indomethacin and interferon-alpha on Th1 and Th2 cytokine synthesis in patients with chronic hepatitis C.

228. Posttransplantation lymphoproliferative disorders.

229. Interferon-alpha combined with ketoprofen as treatment of naïve patients with chronic hepatitis C: a randomized controlled trial.

230. Prophylaxis and treatment of hepatis B virus infection after liver transplantation.

231. Biological and mechanical quality of red blood cells cultured from human umbilical cord blood stem cells.

232. Efficacy of lamivudine therapy for advanced liver disease in patients with precore mutant hepatitis B virus infection awaiting liver transplantation.

233. [Chronic hepatitis B. Recent advances in diagnosis and treatment].

234. Determination of the elastic shear modulus of cultured human red blood cells.

235. Interferon-alpha plus ribavirin and amantadine in patients with post-transplant hepatitis C: results of a pilot study.

236. In vitro effect of thymosin-alpha1 and interferon-alpha on Th1 and Th2 cytokine synthesis in patients with chronic hepatitis C.

237. A cell-culture reactor for the on-line evaluation of radiopharmaceuticals: evaluation of the lumped constant of FDG in human glioma cells.

238. Development of a fixed bed bioreactor for the expansion of human hematopoietic progenitor cells.

239. Analysis of hybridoma cell culture processes by SDS/gel capillary electrophoresis and matrix-assisted laser desorption ionization-time-of-flight MS.

240. Alpha-1-thymosin and transcatheter arterial chemoembolization in hepatocellular carcinoma patients: a preliminary experience.

241. Orthotopic liver transplantation for alcoholic liver disease: rates of survival, complications and relapse.

242. Pilot scale expression and purification of soluble protein A tagged beta 1,6N-acetylglucosaminyltransferase in CHO cells.

243. On-line immunoanalysis of monoclonal antibodies during a continuous culture of hybridoma cells.

244. Automation of selective assays for on-line bioprocess monitoring by flow-injection analysis.

245. Nonmigrainous headache from food allergy.

246. On-line control of an immobilized hybridoma culture with multi-channel flow injection analysis.

247. On-line monitoring of an animal cell culture with multi-channel flow injection analysis.

248. The influence of dissolved oxygen tension on the metabolic activity of an immobilized hybridoma population.

249. Interferon treatment in unresectable hepatocellular carcinoma.

250. Preparation of cellodextrins and isolation of oligomeric side components and their characterization.

Catalog

Books, media, physical & digital resources